Published: 2019-03-25

Lipid profile in type 2 diabetes mellitus: a case-controlled study

Babu Rajendran, Seetha Rami Reddy Mallampati, Sheju Jonathan Jha J., Shameer Hakkim


Background: Atherosclerosis is caused by the combination of type 2 diabetes mellitus and dyslipidemia. Combination of DM and dyslipidemia is associated with increased mortality and morbidity. Hence, it is of utmost importance to know the nature of dyslipidemia in DM for its effective management. The major lipid abnormalities seen in DM are elevated triglyceride levels and lowered HDL-C levels.

Methods: A case-controlled study was initiated in Vinayaka Missions Medical college and hospital for a period of 2 year. Pre-prandial and post-prandial lipid profile was assessed in 50 cases of type 2 DM and was compared with age and sex matched healthy controls satisfying the inclusion and exclusion criteria.

Results: At the end of the study, the mean age±SD was 48.5±5.68 years. The mean HbA1c±SD of the study population was found to be 7.48±1.517. Looking at the lipid profile all cases in fasting state had elevated VLDL-C levels (mean 50.39±60.27), elevated TC (mean 169.70±39.917), elevated TGL (mean 146.04±60.140) and low LDL-C (mean 92.3±27.699) when compared to control group. In the postprandial state, there was a significant raise in TGL level (mean 188±68.59), raised TC (mean 180.74±38.46), decreased HDL-C (mean 38.761±9.028) compared to the fasting state.

Conclusions: Lipid profile of type 2 DM in pre-prandial 12 hour fasting state showed elevated TC, VLDL-C levels and low LDL-C and HDL-C levels. Where as in post prandial state TGL levels were markedly elevated with elevated TC and low HDL-C levels.


Diabetic patients, Dyslipidaemia, Diabetes mellitus, HDL-C, Prandial lipid, VLDL-C level

Full Text:



Havel RJ, Kane JP. Structure and metabolism of plasma lipoproteins. In: Scriver CR, Beaudet AL, Sly WS, eds. The Metabolic and Molecular basis of Inherited Disease, 8th ed. NY: Mcgraw-Hill; 2001;2:2705-2716.

Rader DJ, Hobbs HH. Disorders of lipoprotein metabolism. Harrisons Principles Inter Med. 2005;16(2):2286.

Brunzell JD, Hazzard WR, Motulsky AG, Bierman EL. Evidence for diabetes mellitus and genetic forms of hypertriglyceridemia as independent entities. Metab Clin Exp. 1975;24(10):1115-21.

Abrams JJ, Ginsberg H, Grundy SM. Metabolism of cholesterol and plasma triglycerides in nonketotic diabetes mellitus. Diab. 1982;31(10):903-10.

Grundy SM, Becker D, Clark LT, Cooper RS, Denke MA, Howard J, et al. National Cholesterol Education Program, National Heart, Lung and Blood Institute, National Institute of Health, NIH Publication No. 02-5212, 2002. Available at:

Mengesha AY. Lipid profile among diabetes patients in Gaborone, Botswana. South African Med J. 2006;96(2):147-8.

Raj S, Rajasekharan C, Jayakumar B. Postprandial hypertriglyceridaemia in type 2 diabetic subjects. Int J Diab Dev Ctries. 2006;26(4):161.

Khan HA, Sherwani SI. Significance of HbA1c testing in diagnosis and prognosis of Diabetic Patients. Biomark Insights. 2016;11:95-104.

Howard BV, Cowan LD, Go O, Welty TK, Robbins DC, Lee ET. Strong Heart Study Investigators. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women: the Strong Heart Study. Diab Care. 1998;21(8):1258-65.

Lund SS, Petersen M, Frandsen M, Smidt UM, Parving HH, Vaag AA, et al. Sustained postprandial decrease in plasma levels of LDL cholesterol in patients with type‐2 diabetes mellitus. Scandinavian J Clin lab Investigation. 2008;68(7):628-40.

Rivellese AA, Natale C, Di Marino L, Patti L, Iovine C, Coppola S, et al. Exogenous and endogenous postprandial lipid abnormalities in type 2 diabetic patients with optimal blood glucose control and optimal fasting triglyceride levels. J Clin Endocrinol Metab. 2004;89(5):2153-9.

Madhu SV, Mittal V. Postprandial Lipid Abnormalities inn Type 2 Diabetes Mellitus. Journal of Association of Physicians on India. December 2005;53:1043-6.